Search Results 1931-1940 of 21359 for anti-TNF drugs

  1. Salicylic Acid (Topical Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Salicylic Acid (Topical ... Therasoft Anti-Acne; Tinamed; Ti-Seb; Virasal; Wart ... Drugs & Supplements; Salicylic Acid (Topical ...

  2. Darunavir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Precautions - Mayo Clinic

    Drugs and Supplements · Darunavir ... These reactions are more common if you are female, obese, or have been taking anti-HIV medicines for a long time.

  3. Publications - Jonathan D. Schwartz, D.O., M.P.H. - Mayo Clinic

    Drugs & Supplements · Healthy Lifestyle · Books ... Drugs & Supplements · Healthy Lifestyle · Books ... Synergistic anti-leukemic interactions between ...

  4. A Study of a Computer-Aided Analysis Tool for the Assessment of Pulmonary Fibrosis Treatment - Mayo Clinic

    Patients with suspected or diagnosed pulmonary fibrosis. · Age ≥ 18 years. · Patients who planning to undergo treatment with at least one anti-fibrotic agent OR ...

  5. Publications - David Dingli, M.D., Ph.D. - Mayo Clinic

    Drugs R D. 2024 May 10 [Epub ahead of print] View PubMed; Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA ...

  6. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Prior therapy has not included an anti-CD38 monoclonal antibody. Participant has myeloma disease progression on or after last therapy. Participant must have ...

  7. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... By condition, treatment or drug name. Search tips. Comparison of Anti- ...

  8. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

    Anti HER2 or other “targeted” therapy ≤ 2 weeks. The following patients are not eligible: Pregnant women. Nursing women. Women of childbearing potential ...

  9. Salicylic Acid (Topical Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  10. Neoadjuvant Pembrolizumab - Mayo Clinic

    Concurrent administration of any other anti-tumor therapy. Has received prior therapy with an anti-PD-1, anti-PD-L-1, or anti-PD-L2 agent. Has known active ...